Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 37.


Johnson, Philip, Berhane, Sarah, de Groot, Emily, Toyoda, Hidenori, Tada, Toshifumi, Kumada, Takashi, Satomura, Shinji, Osaki, Yukio, Kudo, Masatoshi, Nishida, Naoshi
et al (show 6 more authors) (2020) AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy. .


Chong, Charing Ching-Ning, Chan, Anthony Wing-Hung, Wong, John, Chu, Cheuk-Man, Chan, Stephen Lam, Lee, Kit-Fai, Yu, Simon Chun-Ho, To, Ka-Fai, Johnson, Philip ORCID: 0000-0003-1404-0209 and Lai, Paul Bo-San
(2018) Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 16 (3). pp. 163-170.


Chan, Stephen L, Mo, Frankie, Johnson, Philip ORCID: 0000-0003-1404-0209, Li, Leung, Tang, Nelson, Loong, Herbert, Chan, Anthony WH, Koh, Jane, Chan, Anthony TC and Yeo, Winnie
(2015) Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30 (10). pp. 1529-1535.


Johnson, Philip ORCID: 0000-0003-1404-0209, Zhou, Qing, Dao, Doan Y and Lo, YM Dennis
(2022) Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 19 (10). pp. 670-681.


Innes, Hamish, Hamill, Victoria, McDonald, Scott A, Hayes, Peter C, Johnson, Philip ORCID: 0000-0003-1404-0209, Dillon, John F, Bishop, Jen, Yeung, Alan, Went, April, Barclay, Stephen T
et al (show 4 more authors) (2022) Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication? AMERICAN JOURNAL OF GASTROENTEROLOGY, 117 (9). pp. 1454-1461.


Innes, Hamish ORCID: 0000-0003-0565-1083, Johnson, Philip ORCID: 0000-0003-1404-0209, McDonald, Scott A, Hamill, Victoria, Yeung, Alan, Dillon, John F, Hayes, Peter C, Went, April, Barclay, Stephen T, Fraser, Andrew
et al (show 3 more authors) (2022) Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making. Gastro Hep Advances, 1 (2). pp. 129-136.


Alsefri, Maha ORCID: 0000-0003-3576-9680
(2023) Development and Application of Joint Modelling of Longitudinal and Event-Time Data in Frequentist and Bayesian Settings: Addressing the Uncertainty of Association Structure Selection. PhD thesis, University of Liverpool.


Karlsen, Tom H, Sheron, Nick, Zelber-Sagi, Shira, Carrieri, Patrizia, Dusheiko, Geoffrey, Bugianesi, Elisabetta, Pryke, Rachel, Hutchinson, Sharon J, Sangro, Bruno, Martin, Natasha K
et al (show 47 more authors) (2022) The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. LANCET, 399 (10319). pp. 61-116.


Johnson, Philip ORCID: 0000-0003-1404-0209
(2019) The Epidemiology of Hepatocellular Carcinoma. In: Liver Cancers. Springer International Publishing,Switzerland, pp. 3-11. ISBN 9783319922157


Cucchetti, Alessandro ORCID: 0000-0001-5269-1964, Johnson, Philip ORCID: 0000-0003-1404-0209, Capurso, Gabriele, Crippa, Stefano, Pacilio, Carlo Alberto, Fabbri, Carlo, Falconi, Massimo ORCID: 0000-0001-9654-7243 and Ercolani, Giorgio ORCID: 0000-0003-4334-5167
(2023) European' health care indicators and pancreatic cancer incidence and mortality: A mediation analysis of Eurostat data and Global Burden of Disease Study 2019. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 23 (7). pp. 829-835.


Best, Jan, Bechmann, Lars P, Sowa, Jan-Peter, Sydor, Svenja, Dechene, Alexander, Pflanz, Kristina, Bedreli, Sotiria, Schotten, Clemens, Geier, Andreas, Berg, Thomas
et al (show 23 more authors) (2020) GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 18 (3). 728-+.


Schotten, Clemens, Ostertag, Bastian, Sowa, Jan-Peter, Manka, Paul, Bechmann, Lars P, Hilgard, Gudrun, Marquardt, Claudio, Wichert, Marc, Toyoda, Hidenori, Lange, Christian M
et al (show 4 more authors) (2021) GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients. Pharmaceuticals, 14 (8). p. 735.


Best, Jan, Bechmann, Lars P, Sydor, Svenja, Dechêne, Alexander, Pflanz, Kristina, Bedreli, Sotiria, Schotten, Clemens, Geier, Andreas, Berg, Thomas, Fischer, Janett
et al (show 22 more authors) (2020) The GALAD Score as Potential Screening Test for Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis: An International Multicenter Study. Journal of Clinical Gastroenterology and Hepatology.


Park, Joong-Won, Chen, Minshan, Colombo, Massimo, Roberts, Lewis R ORCID: 0000-0001-7885-8574, Schwartz, Myron, Chen, Pei-Jer, Kudo, Masatoshi ORCID: 0000-0002-4102-3474, Johnson, Philip ORCID: 0000-0003-1404-0209, Wagner, Samuel, Orsini, Lucinda S
et al (show 1 more authors) (2015) Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver international : official journal of the International Association for the Study of the Liver, 35 (9). pp. 2155-2166.


Ueshima, Kazuomi, Nishida, Naoshi, Hagiwara, Satoru, Aoki, Tomoko, Minami, Tomohiro, Chishina, Hirokazu, Takita, Masahiro, Minami, Yasunori, Ida, Hiroshi, Takenaka, Mamoru
et al (show 7 more authors) (2019) Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study. CANCERS, 11 (7). E952-.


Pinna, AD, Yang, T, Mazzaferro, V, De Carlis, Luciano, Zhou, Jian, Roayaie, Sasan, Shen, Feng, Sposito,, Carlo, Cescon, Matteo, Di Sandro, Stefano
et al (show 3 more authors) (2018) Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma. Annals of Surgery, 268 (5). pp. 868-875.


Edeline, Julien, Lamarca, Angela, McNamara, Mairead G, Jacobs, Timothy, Hubner, Richard A, Palmer, Dan ORCID: 0000-0002-7147-5703, Koerkamp, Bas Groot, Johnson, Philip ORCID: 0000-0003-1404-0209, Guiu, Boris and Valle, Juan W
(2021) Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. CANCER TREATMENT REVIEWS, 99. 102258-.


Cucchetti, Alessandro, Gramenzi, Annagiulia, Johnson, Philip ORCID: 0000-0003-1404-0209, Giannini, Edoardo G, Tovoli, Francesco, Rapaccini, Gian Ludovico, Marra, Fabio, Cabibbo, Giuseppe, Caturelli, Eugenio, Gasbarrini, Antonio
et al (show 86 more authors) (2021) Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. European Journal of Cancer, 158. pp. 133-143.


Chong, Charing CN, Lee, Kit-Fai, Chu, Cheuk-Man, Chan, Anthony WH, Wong, John, Chan, Stephen L, Lok, Hon-Ting, Fung, Andrew KY, Fong, Anthony KW, Cheung, Yue S
et al (show 3 more authors) (2018) Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection. HPB, 20 (6). pp. 546-554.


Johnson, Philip ORCID: 0000-0003-1404-0209
(2023) Mortality rates among patients achieving a hepatitis C cure in the interferon-free treatment era: data from three population cohorts. BMJ: British Medical Journal.


Hamill, Victoria, Wong, Stanley, Benselin, Jennifer, Krajden, Mel, Hayes, Peter C, Mutimer, David, Yu, Amanda, Dillon, John F, Gelson, William, Garcia, Hector A Velasquez
et al (show 21 more authors) (2023) Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study. BMJ-BRITISH MEDICAL JOURNAL, 382. e074001-.


Cabibbo, Giuseppe, Cucchetti, Alessandro, Cammà, Calogero, Casadei-Gardini, Andrea, Celsa, Ciro, Emanuele Maria Rizzo, Giacomo, Johnson, Philip ORCID: 0000-0003-1404-0209 and Ercolani, Giorgio
(2019) Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials. Future Oncology, 15 (29). pp. 3411-3422.


Innes, Hamish, Jepsen, Peter, McDonald, Scott, Dillon, John, Hamill, Victoria, Yeung, Alan, Benselin, Jennifer, Went, April, Fraser, Andrew, Bathgate, Andrew
et al (show 9 more authors) (2021) Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection. JHEP REPORTS, 3 (6). 100384-.


Vogel, Arndt, Kelley, Robin Katie, Johnson, Philip ORCID: 0000-0003-1404-0209, Merle, Philippe, Yau, Thomas, Kudo, Masatoshi, Meyer, Tim and Rimassa, Lorenza
(2023) Predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review. LIVER CANCER, 12 (4). pp. 372-391.


Johnson, Philip ORCID: 0000-0003-1404-0209
(2024) Progression of Chronic Liver Disease to Hepatocellular Carcinoma: Implications for Surveillance and Management. BJ Cancer Reports.


Johnson, Philip ORCID: 0000-0003-1404-0209 and Berhane, Sarah
(2016) Protein Biomarkers in the Management of Hepatocellular Carcinoma: Novel Combinatory Approaches. In: HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND TREATMENT, 3RD EDITION. Springer International Publishing,Switzerland, pp. 331-338. ISBN 978-3-319-34212-2


Johnson, Philip ORCID: 0000-0003-1404-0209, Lai, Paul BS and Toyoda, Hidenori
(2016) Reply to: Comment on: 'Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'. BRITISH JOURNAL OF CANCER, 115 (5). E6-E6.


Schweitzer, Nora, Fischer, Mareike, Kirstein, Martha M, Berhane, Sarah, Kottas, Martina, Sinn, Marianne, Gonzalez-Carmona, Maria A, Balta, Zeynep, Weismueller, Tobias J, Strassburg, Christian P
et al (show 6 more authors) (2017) Risk estimation for biliary tract cancer: Development and validation of a prognostic score. LIVER INTERNATIONAL, 37 (12). pp. 1852-1860.


Berhane, Sarah, Toyoda, Hidenori, Tada, Toshifumi, Kumada, Takashi, Kagebayashi, Chiaki, Satomura, Shinji, Schweitzer, Nora, Vogel, Arndt, Manns, Michael P, Benckert, Julia
et al (show 15 more authors) (2016) Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 14 (6). 875-+.


Hughes, David M ORCID: 0000-0002-1287-9994, Berhane, Sarah, Emily de Groot, CA, Toyoda, Hidenori, Tada, Toshifumi, Kumada, Takashi, Satomura, Shinji, Nishida, Naoshi, Kudo, Masatoshi, Kimura, Toru
et al (show 6 more authors) (2020) Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology, 19 (1). 162-+.


Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208 and Johnson, Philip ORCID: 0000-0003-1404-0209
(2022) Sorafenib is associated with reduced tumour growth rate and liver function deterioration in HCV-induced hepatocellular carcinoma. Journal of Hepatology, 75 (4). pp. 879-887.


Kudo, Masatoshi, Ueshima, Kazuomi, Yokosuka, Osamu, Ogasawara, Sadahisa, Obi, Shuntaro, Izumi, Namiki, Aikata, Hiroshi, Nagano, Hiroaki, Hatano, Etsuro, Sasaki, Yutaka
et al (show 13 more authors) (2018) Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 3 (6). pp. 424-432.


Mosconi, Cristina, O'Rourke, Joanne, Kloeckner, Roman, Sturm, Lukas, Golfieri, Rita, Celsa, Ciro, Fateen, Waleed, Odisio, Bruno C, Garanzini, Enrico Matteo, Peck-Radosavljevic, Markus
et al (show 11 more authors) (2023) Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 46 (4). pp. 449-459.


Meyer, Tim and Johnson, Philip ORCID: 0000-0003-1404-0209
(2019) Trial endpoints for systemic therapy in patients with hepatocellular carcinoma. JOURNAL OF HEPATOLOGY, 70 (6). pp. 1060-1061.


Berhane, Sarah, Fox, Richard, Garcia-Finana, Marta ORCID: 0000-0003-4939-0575, Cucchetti, Alessandro and Johnson, Philip ORCID: 0000-0003-1404-0209
(2019) Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment. British Journal of Cancer, 121 (2). pp. 117-124.


Johnson, Philip, Dhanaraj, Sofi, Ma, Yuk Ting, Bonnett, Laura ORCID: 0000-0002-6981-9212 and Berhane, Sarah
(2020) The prognostic and diagnostic significance of the neutrophil to lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. .


Johnson, Philip ORCID: 0000-0003-1404-0209, Dhanaraj, Sofi, Ma, Yuk Ting, Bonnett, Laura and Berhane, Sarah
(2020) The prognostic and diagnostic significance of the neutrophil to lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. Journal of Hepatology, 73. S388-S388.

This list was generated on Sat Apr 6 15:46:20 2024 BST.